W 
116.87
+4.59%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$12.46bn
FY2016FY2025
Net income
−$313.0m
FY2016FY2025
Free cash flow
$329.0m
FY2016FY2025
Shareholders' equity
−$2.78bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.46bn | $11.85bn | $12.00bn | $12.22bn | $13.71bn | $14.15bn | $9.13bn | $6.78bn | $4.72bn | $3.38bn |
| Gross profit | $3.77bn | $3.57bn | $3.67bn | $3.42bn | $3.90bn | $4.11bn | $2.15bn | $1.59bn | $1.12bn | $807.8m |
| Research and development | — | $257.0m | $279.0m | $224.0m | $171.0m | $132.0m | $82.0m | $51.3m | $34.5m | $21.6m |
| Operating income | $17.0m | −$453.0m | −$813.0m | −$1.38bn | −$94.0m | $360.3m | −$927.4m | −$473.5m | −$234.7m | −$196.2m |
| Net income | −$313.0m | −$492.0m | −$738.0m | −$1.33bn | −$131.0m | $185.0m | −$984.6m | −$504.1m | −$244.6m | −$194.4m |
| Diluted earnings per share | -2.41 | -3.94 | -6.25 | -12.32 | -1.25 | 1.81 | -10.55 | -5.57 | -2.78 | -2.27 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.44bn | $3.46bn | $3.47bn | $3.58bn | $4.57bn | $4.57bn | $2.95bn | $1.89bn | $1.21bn | $761.7m |
| Cash and short-term investments | $1.54bn | $1.37bn | $1.35bn | $1.28bn | $2.40bn | $2.59bn | $987.0m | $963.7m | $620.0m | $348.6m |
| Total liabilities | $6.22bn | $6.21bn | $6.18bn | $6.13bn | $6.19bn | $5.76bn | $3.90bn | $2.22bn | $1.26bn | $682.3m |
| Debt | $3.27bn | $3.12bn | $3.21bn | $3.14bn | $3.05bn | $2.66bn | $1.46bn | $922.0m | $415.5m | $28.9m |
| Shareholders' equity | −$2.78bn | −$2.75bn | −$2.71bn | −$2.55bn | −$1.62bn | −$1.19bn | −$944.2m | −$330.7m | −$48.3m | $79.4m |
| Shares outstanding | 130m | 125m | 118m | 108m | 105m | 102m | 93m | 90m | 88m | 86m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $534.0m | $317.0m | $349.0m | −$674.0m | $410.0m | $1.42bn | −$196.8m | $84.9m | $33.6m | $62.8m |
| Capital spending | −$205.0m | −$234.0m | −$351.0m | −$458.0m | −$280.0m | −$334.4m | −$400.9m | −$222.0m | −$146.9m | −$128.1m |
| Free cash flow | $329.0m | $83.0m | −$2.0m | −$1.13bn | $130.0m | $1.08bn | −$597.7m | −$137.1m | −$113.2m | −$65.3m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.52bn | $2.93bn | $3.34bn | $3.12bn | $3.27bn | $2.73bn | $3.12bn | $2.88bn |
| Gross profit | $1.05bn | $880.0m | $1.01bn | $934.0m | $984.0m | $837.0m | $941.0m | $873.0m |
| Operating income | $41.0m | $13.0m | $69.0m | $38.0m | $55.0m | −$122.0m | −$112.0m | −$74.0m |
| Net income | −$1.0m | −$105.0m | −$116.0m | −$99.0m | $15.0m | −$113.0m | −$128.0m | −$74.0m |
| Diluted earnings per share | -0.01 | -0.80 | -0.89 | -0.76 | 0.12 | -0.87 | -1.02 | -0.59 |
| Cash from operations | $360.0m | −$52.0m | $202.0m | $155.0m | $273.0m | −$96.0m | $162.0m | $49.0m |
| Capital spending | −$3.0m | −$54.0m | −$57.0m | −$62.0m | −$43.0m | −$43.0m | −$60.0m | −$58.0m |
| Free cash flow | $357.0m | −$106.0m | $145.0m | $93.0m | $230.0m | −$139.0m | $102.0m | −$9.0m |
| Total assets | $2.98bn | $2.87bn | $3.44bn | $3.12bn | $3.28bn | $3.42bn | $3.46bn | $3.41bn |
| Cash and short-term investments | $1.14bn | $1.06bn | $1.54bn | $1.23bn | $1.38bn | $1.37bn | $1.37bn | $1.33bn |
| Debt | $2.80bn | $2.93bn | $3.27bn | $2.94bn | $3.04bn | $3.24bn | $3.29bn | $3.22bn |
| Shareholders' equity | −$2.79bn | −$2.84bn | −$2.78bn | −$2.77bn | −$2.72bn | −$2.81bn | −$2.75bn | −$2.73bn |
Financial ratios
Data as of 3 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 30.2% | 30.2% | 30.6% | 28.0% | 28.4% | 29.1% | — |
| Operating margin | 0.1% | -3.8% | -6.8% | -11.3% | -0.7% | 2.5% | — |
| Net margin | -2.5% | -4.2% | -6.1% | -10.9% | -1.0% | 1.3% | — |
| Return on equity | 11.3% | 17.9% | 27.3% | 52.2% | 8.1% | -15.5% | — |
| Return on assets | -9.1% | -14.2% | -21.2% | -37.2% | -2.9% | 4.0% | — |
| Free cash flow yield | 5.6% | 4.4% | 5.9% | -2.0% | 6.5% | 16.9% | — |
| Revenue growth | 5.1% | -1.3% | -1.8% | -10.9% | -3.1% | 55.0% | — |
| Earnings growth | -36.4% | -33.3% | -44.6% | 916.0% | -170.8% | -118.8% | — |
| Current ratio | 0.94x | 0.79x | 0.85x | 0.93x | 1.36x | 1.41x | — |
| Debt to equity | -1.18x | -1.19x | -1.23x | -1.28x | -1.95x | -2.31x | — |
| Equity ratio | -80.9% | -79.6% | -77.9% | -71.2% | -35.4% | -26.1% | — |
| Interest coverage | 0.20x | -15.62x | -47.82x | -51.26x | -2.94x | 2.47x | — |
| R&D as a share of sales | — | 2.2% | 2.3% | 1.8% | 1.2% | 0.9% | 0.9% |
| Buybacks as a share of market value | -4.0% | -5.9% | -9.3% | -2.9% | -2.6% | -9.7% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 0.6% | -2.5% | 18.7% |
| Operating income | — | -45.7% | — |
| Net income | -38.3% | — | 15.0% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 30.2% | 29.7% | 29.4% | 27.9% |
| Operating margin | -1.8% | -5.4% | -3.1% | -4.2% |
| Net margin | -3.3% | -5.9% | -3.7% | -4.7% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -41.7 | -11.3 | -9.9 | -2.7 | -152.3 | 125.0 | -8.6 | -16.2 | -28.8 | -15.4 |
| Price to sales | 1.1 | 0.5 | 0.6 | 0.3 | 1.5 | 1.6 | 0.9 | 1.2 | 1.5 | 0.9 |
Market value over time
30 Nov 2016 to 2 Oct 2026, in USD
$3.10bn$13.37bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 117% | -32% | 95% | -83% | -31% | 237% | -1% | 4% | 117% | -15% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.